Loading...

Skip to main content

Call us on + 1 (800) 604-9114 for more information about our products

Looking for specific datasheet Manual/COA/MSDS?
Request a Manual/COA/MSDS

Interested to get a quote about our products?
Request a Quote

Typical Testing Data/Standard Curve (for reference only)

Human Ranibizumad (Lucentis) ELISA Kit

Ranibizumad (Lucentis) (Human) ELISA Kit

Reactivity
Human
Synonyms
Ranibizumad (Lucentis); Ranibizumad (Lucentis) (Human) ELISA Kit; Ranibizumad (Lucentis) elisa kit
Ordering
For Research Use Only!
Reactivity
Human
Specificity
This kit for the quantitative measurement of Ranibizumad
Assay Type
Sandwich
Samples
Human serum, plasma, tissue homogenates, culture supernatants and other biological fluids
Detection Range
1.22-625ng/ml
Detection Method
Absorbance: 450nm
Features & Benefits
Easy, convenient, sensitive and time-saving method to measure the level of Ranibizumad in human serum and plasma.
Preparation and Storage
Store at -20 degree C
Shelf life: ~12 months

Typical Testing Data/Standard Curve (for reference only)

Typical Testing Data/Standard Curve (for reference only)
Related Product Information for Ranibizumad (Lucentis) elisa kit
Ranibizumab (Lucentis) is a recombinant human IgG1 monoclonal antibody fragment (Fab) that blocks angiogenesis by inhibiting vascular endothelial growth factor-A (VEGF-A) isoforms. The humanized anti-VEGF monoclonal antibody, Ranibizumab, has been approved by the FDA for treatment of patients with wet age-related macular degeneration. Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in people over the age of 50 in the developed world. Although an estimated 80% of patients with AMD have the non-neo vascular form, the neo vascular (wet or exudative) form is responsible for almost 90% of severe visual loss resulting from AMD. Currently, the most commonly used VEGF antagonists are ranibizumab (Lucentis, Genentech, Inc.) and Ranibizumab (Avastin; Genentech, Inc.). Ranibizumab, which is an antibody fragment form the Ranibizumab molecule with an increased binding affinity for all forms of VEGF, has been approved for the treatment of patients with neo-vascular AMD by the Food and Drug Administration and by the European Medicines Agency. Ranibizumab ELISA kit is developed for the quantification of Ranibizumab concentration in human serum or plasma with high sensitivity and reproducibility.
Product Categories/Family for Ranibizumad (Lucentis) elisa kit

Similar Products

Product Notes

The Human Ranibizumad (Lucentis) (Catalog #AAA849101) is an ELISA Kit and is intended for research purposes only. The product is available for immediate purchase. The AAA849101 ELISA Kit recognizes Human Ranibizumad (Lucentis). It is sometimes possible for the material contained within the vial of "Ranibizumad (Lucentis), ELISA Kit" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.

Precautions

All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.

Disclaimer

Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.

Item has been added to Shopping Cart

If you are ready to order, navigate to Shopping Cart and get ready to checkout.

Looking for a specific manual?
Request a Manual

Request more Information

Please complete the form below and a representative will contact you as soon as possible.

Request a Manual

Please complete the form below and a representative will contact you as soon as possible.

Request a Quote

Please complete the form below and a representative will contact you as soon as possible.